AI-generated summary
The authors report a systematic review of pharmacological therapies and nutritional supplements for seasonal affective disorder, a winter-recurring depressive subtype. They describe light therapy and fluoxetine as the acute treatments they consider proven and effective, and bupropion as the only registered drug for prevention. They conclude the field needs larger, reproducible randomized controlled trials.
- Who or what was studied
- People with seasonal affective disorder (not quantified in the abstract)
- Limits stated in the abstract
- The abstract states that research on SAD treatment is lacking and that current trials are not sufficiently large or reproducible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.